Daily as of 3 Nov 16:00 ET
- Price
- below both $3.05 vs 50 $4.48 / 200 $7.31
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 1 Oct 2025 · projected 25 bars out
SPRY | ARS PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$3.05
$0.00 (0.00%)
ARS Pharmaceuticals (SPRY) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.
The 50 SMA has sat below the 200 on the daily since Oct 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $3.38 vs 50 $7.85 / 200 $9.35
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 16:00 ET
- Price
- below both $3.05 vs 50 $4.00 / 200 $5.83
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 21 Jul 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 21 Jul 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| 18 Jun 2026 | 🟨Golden | 4-hour | 25 bars out | Not tested |
| 23 Feb 2026 | 💀Death | 4-hour | 20 bars out | Not tested |
| 5 Jan 2026 | 🟨Golden | 4-hour | 21 bars out | Not tested |
| 1 Oct 2025 | 💀Death steep | daily | 25 bars out | Not tested |
About SPRY
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$7M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall